The additional agreement with University of Georgia further strengthens ECO’s pipeline of development-stage poultry vaccines, and targets a pathogen (M. synoviae) of significant commercial importance. We look forward to further development updates with interest, and reiterate our positive stance on ECO as a core holding in the Animal Health sector.
05 Feb 2019
Second vaccine deal signed with University of Georgia
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Second vaccine deal signed with University of Georgia
ECO Animal Health Group plc (EAH:LON) | 84.5 0.4 0.6% | Mkt Cap: 57.2m
- Published:
05 Feb 2019 -
Author:
Dr Jens Lindqvist -
Pages:
3
The additional agreement with University of Georgia further strengthens ECO’s pipeline of development-stage poultry vaccines, and targets a pathogen (M. synoviae) of significant commercial importance. We look forward to further development updates with interest, and reiterate our positive stance on ECO as a core holding in the Animal Health sector.